Generating cell targeting aptamers for nanotheranostics using cell-SELEX

Theranostics

Volumn 6, Issue 9, 2016, Pages 1440-1452

  Lyu, Yifan ^a,b,c,d   Chen, Guang ^a,b,c,d   Shangguan, Dihua ^a,b,c,d   Zhang, Liqin ^a,b,c,d   Wan, Shuo ^a,b,c,d   Wu, Yuan ^a,b,c,d   Zhang, Hui ^a,b,c,d   Duan, Lian ^a,b,c,d   Liu, Chao ^a,b,c,d   You, Mingxu ^a,b,c,d   Wang, Jie ^a,b,c,d   Tan, Weihong ^e  

^a INSTITUTE OF CHINESE MATERIA MEDICA   (China)

^b HUNAN UNIVERSITY   (China)

^c INSTITUTE OF CHEMISTRY   (China)

^d UNIVERSITY OF CHINESE ACADEMY OF SCIENCES   (China)

^e UNIVERSITY OF FLORIDA   (United States)

Author keywords

Aptamer drug conjugates; Aptamers; Cell SELEX; DNA network; Nanotheranostic

Indexed keywords

APTAMER; CELL TARGETING APTAMER; UNCLASSIFIED DRUG;

APTAMER CHARACTERIZATION; APTAMER IDENTIFICATION; APTAMER SELECTION; BINDING AFFINITY; BINDING SITE; CELL SURFACE; CELL SYSTEMATIC EVOLUTION OF LIGANDS BY EXPONENTIAL ENRICHMENT TECHNOLOGY; CELLS BY BODY ANATOMY; CHEMICAL PROCEDURES; CONFORMATION; DISSOCIATION CONSTANT; DNA LIBRARY; DNA STRUCTURE; FLOW CYTOMETRY; GENE AMPLIFICATION; HUMAN; HYDROPHOBICITY; INCUBATION TIME; LIVE CELL; MEDICAL TECHNOLOGY; MOLECULAR DYNAMICS; MOLECULAR LIBRARY; NONHUMAN; OLIGONUCLEOTIDE LIBRARY; POLYMERASE CHAIN REACTION; PROCESS OPTIMIZATION; PROTEIN EXPRESSION; PROTEIN SECONDARY STRUCTURE; REVIEW; STRUCTURE ACTIVITY RELATION; STRUCTURE ANALYSIS; SURFACE CHARGE; SYNTHESIS; TARGET BINDING CONFORMATION; THERANOSTIC NANOMEDICINE; ANIMAL; CYTOLOGY; PROCEDURES; SYSTEMATIC EVOLUTION OF LIGANDS BY EXPONENTIAL ENRICHMENT APTAMER TECHNIQUE;

ANIMALS; CYTOLOGICAL TECHNIQUES; HUMANS; SELEX APTAMER TECHNIQUE; THERANOSTIC NANOMEDICINE;

EID: 84991577565     PISSN: None     EISSN: 18387640     Source Type: Journal    
DOI: 10.7150/thno.15666     Document Type: Review

References (75)

1. Tan W, Donovan MJ, Jiang J. Aptamers from cell-based selection for bioanalytical applications. Chem Rev. 2013; 113: 2842-62
2. Ellington AD, Szostak JW. In vitro selection of RNA molecules that bind specific ligands. Nature. 1990; 346: 818-22
3. Tuerk C, Gold L. Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase. Science. 1990; 249: 505-10
4. Lee JF, Stovall GM, Ellington AD. Aptamer therapeutics advance. Curr Opin Chem Biol. 2006; 10: 282-9
5. Morris KN, Jensen KB, Julin CM, Weil M, Gold L. High affinity ligands from in vitro selection: Complex targets. Proc Natl Acad Sci U S A. 1998; 95: 2902-7
6. Blank M, Weinschenk T, Priemer M, Schluesener H. Systematic Evolution of a DNA Aptamer Binding to Rat Brain Tumor Microvessels: SELECTIVE TARGETING OF ENDOTHELIAL REGULATORY PROTEIN PIGPEN. J Biol Chem. 2001; 276: 16464-8
7. Daniels DA, Chen H, Hicke BJ, Swiderek KM, Gold L. A tenascin-C aptamer identified by tumor cell SELEX: Systematic evolution of ligands by exponential enrichment. Proc Natl Acad Sci U S A. 2003; 100: 15416-21
8. Wang C, Zhang M, Yang G, Zhang D, Ding H, Wang H, et al. Single-stranded DNA aptamers that bind differentiated but not parental cells: subtractive systematic evolution of ligands by exponential enrichment. J Biotechnol. 2003; 102: 15-22
9. Shangguan D, Li Y, Tang Z, Cao ZC, Chen HW, Mallikaratchy P, et al. Aptamers evolved from live cells as effective molecular probes for cancer study. Proc Natl Acad Sci U S A. 2006; 103: 11838-43
10. Jiang G, Zhang M, Yue B, Yang M, Carter C, Al-Quran SZ, et al. PTK7: a new biomarker for immunophenotypic characterization of maturing T cells and T cell acute lymphoblastic leukemia. Leuk Res. 2012; 36: 1347-53
11. Shangguan D, Cao Z, Meng L, Mallikaratchy P, Sefah K, Wang H, et al. Cell-Specific Aptamer Probes for Membrane Protein Elucidation in Cancer Cells. J Proteome Res. 2008; 7: 2133-9
12. Tang Z, Shangguan D, Wang K, Shi H, Sefah K, Mallikratchy P, et al. Selection of Aptamers for Molecular Recognition and Characterization of Cancer Cells. Anal Chem. 2007; 79: 4900-7
13. Chen HW, Medley CD, Sefah K, Shangguan D, Tang Z, Meng L, et al. Molecular Recognition of Small-Cell Lung Cancer Cells Using Aptamers. ChemMedChem. 2008; 3: 991-1001
14. Shangguan D, Meng L, Cao ZC, Xiao Z, Fang X, Li Y, et al. Identification of Liver Cancer-Specific Aptamers Using Whole Live Cells. Anal Chem. 2008; 80: 721-8
15. Li W-M, Bing T, Wei J-Y, Chen Z-Z, Shangguan D-H, Fang J. Cell-SELEX-based selection of aptamers that recognize distinct targets on metastatic colorectal cancer cells. Biomaterials. 2014; 35: 6998-7007
16. Wang Y, Luo Y, Bing T, Chen Z, Lu M, Zhang N, et al. DNA Aptamer Evolved by Cell-SELEX for Recognition of Prostate Cancer. PLoS One. 2014; 9: e100243
17. Sefah K, Bae K-M, Phillips JA, Siemann DW, Su Z, McClellan S, et al. Cell-based selection provides novel molecular probes for cancer stem cells. Int J Cancer. 2013; 132: 2578-88
18. Sefah K, Tang ZW, Shangguan DH, Chen H, Lopez-Colon D, Li Y, et al. Molecular recognition of acute myeloid leukemia using aptamers. Leukemia. 2009; 23: 235-44
19. Tang Z, Parekh P, Turner P, Moyer RW, Tan W. Generating Aptamers for Recognition of Virus-Infected Cells. Clin Chem. 2009; 55: 813-22
20. Zhao Z, Xu L, Shi X, Tan W, Fang X, Shangguan D. Recognition of subtype non-small cell lung cancer by DNA aptamers selected from living cells. Analyst. 2009; 134: 1808-14
21. Parekh P, Tang Z, Turner PC, Moyer RW, Tan W. Aptamers Recognizing Glycosylated Hemagglutinin Expressed on the Surface of Vaccinia Virus-Infected Cells. Anal Chem. 2010; 82: 8642-9
22. Sefah K, Meng L, Lopez-Colon D, Jimenez E, Liu C, Tan W. DNA Aptamers as Molecular Probes for Colorectal Cancer Study. PLoS One. 2010; 5: e14269
23. Wu X, Zhao Z, Bai H, Fu T, Yang C, Hu X, et al. DNA Aptamer Selected against Pancreatic Ductal Adenocarcinoma for in vivo Imaging and Clinical Tissue Recognition. Theranostics. 2015; 5: 985-94
24. Wang H, Liang J, Ma Y, Sun B, Li X, Wei Y, et al. Identification of a novel molecular probe for recognition of human osteosarcoma cell using the cell-SELEX method. Int J Clin Exp Med. 2015; 8: 18151-7
25. Lu M, Zhou L, Zheng X, Quan Y, Wang X, Zhou X, et al. A novel molecular marker of breast cancer stem cells identified by cell-SELEX method. Cancer Biomark. 2015; 15: 163-70
26. Li X, An Y, Jin J, Zhu Z, Hao L, Liu L, et al. Evolution of DNA Aptamers through in Vitro Metastatic-Cell-Based Systematic Evolution of Ligands by Exponential Enrichment for Metastatic Cancer Recognition and Imaging. Anal Chem. 2015; 87: 4941-8
27. Benedetto G, Hamp TJ, Wesselman PJ, Richardson C. Identification of Epithelial Ovarian Tumor-Specific Aptamers. Nucleic Acid Ther. 2015; 25: 162-72
28. Rong Y, Chen H, Zhou X-F, Yin C-Q, Wang B-C, Peng C-W, et al. Identification of an aptamer through whole cell-SELEX for targeting high metastatic liver cancers. Oncotarget. 2016; 7: 8282-94
29. Zhu G, Zheng J, Song E, Donovan M, Zhang K, Liu C, et al. Self-assembled, aptamer-tethered DNA nanotrains for targeted transport of molecular drugs in cancer theranostics. Proc Natl Acad Sci U S A. 2013; 110: 7998-8003
30. Zhu G, Hu R, Zhao Z, Chen Z, Zhang X, Tan W. Noncanonical self-assembly of multifunctional DNA nanoflowers for biomedical applications. J Am Chem Soc. 2013; 135: 16438-45
31. Wang R, Zhu G, Mei L, Xie Y, Ma H, Ye M, et al. Automated modular synthesis of aptamer-drug conjugates for targeted drug delivery. J Am Chem Soc. 2014; 136: 2731-4
32. Zhu G, Cansiz S, You M, Qiu L, Han D, Zhang L, et al. Nuclease-resistant synthetic drug-DNA adducts: programmable drug-DNA conjugation for targeted anticancer drug delivery. NPG Asia Mater. 2015; 7: e169
33. You M, Peng L, Shao N, Zhang L, Qiu L, Cui C, et al. DNA "nano-claw": logic-based autonomous cancer targeting and therapy. J Am Chem Soc. 2014; 136: 1256-9
34. You M, Zhu G, Chen T, Donovan MJ, Tan W. Programmable and multiparameter DNA-based logic platform for cancer recognition and targeted therapy. J Am Chem Soc. 2014; 137: 667-74
35. Stoltenburg R, Reinemann C, Strehlitz B. SELEX-A (r)evolutionary method to generate high-affinity nucleic acid ligands. Biomol Eng. 2007; 24: 381-403
36. Sefah K, Shangguan D, Xiong X, O'Donoghue MB, Tan W. Development of DNA aptamers using Cell-SELEX. Nat Protoc. 2010; 5: 1169-85
37. Benner SA. Understanding nucleic acids using synthetic chemistry. Acc Chem Res. 2004; 37: 784-97
38. Sefah K, Yang Z, Bradley KM, Hoshika S, Jiménez E, Zhang L, et al. In vitro selection with artificial expanded genetic information systems. Proc Natl Acad Sci U S A. 2014; 111: 1449-54
39. Zhang L, Yang Z, Sefah K, Bradley KM, Hoshika S, Kim M-J, et al. Evolution of Functional Six-Nucleotide DNA. J Am Chem Soc. 2015; 137: 6734-7
40. Hicke BJ, Marion C, Chang Y-F, Gould T, Lynott CK, Parma D, et al. Tenascin-C Aptamers Are Generated Using Tumor Cells and Purified Protein. J Biol Chem. 2001; 276: 48644-54
41. Liu J, Liu H, Sefah K, Liu B, Pu Y, Van Simaeys D, et al. Selection of Aptamers Specific for Adipose Tissue. PLoS One. 2012; 7: e37789
42. Cao X, Li S, Chen L, Ding H, Xu H, Huang Y, et al. Combining use of a panel of ssDNA aptamers in the detection of Staphylococcus aureus. Nucleic Acids Res. 2009; 37: 4621-8
43. Turek D, Van Simaeys D, Johnson J, Ocsoy I, Tan W. Molecular recognition of live methicillin-resistant staphylococcus aureus cells using DNA aptamers. World J Transl Med. 2013; 2: 67
44. Bayrac AT, Sefah K, Parekh P, Bayrac C, Gulbakan B, Oktem HA, et al. In vitro selection of DNA aptamers to glioblastoma multiforme. ACS Chem Neurosci. 2011; 2: 175-81
45. Bing T, Yang X, Mei H, Cao Z, Shangguan D. Conservative secondary structure motif of streptavidin-binding aptamers generated by different laboratories. Bioorg Med Chem. 2010; 18: 1798-805
46. Shangguan D, Tang Z, Mallikaratchy P, Xiao Z, Tan W. Optimization and modifications of aptamers selected from live cancer cell lines. Chembiochem. 2007; 8: 603-6
47. Legiewicz M, Yarus M. A more complex isoleucine aptamer with a cognate triplet. J Biol Chem. 2005; 280: 19815-22
48. Manimala JC, Wiskur SL, Ellington AD, Anslyn EV. Tuning the specificity of a synthetic receptor using a selected nucleic acid receptor. J Am Chem Soc. 2004; 126: 16515-9
49. Sayer NM, Cubin M, Rhie A, Bullock M, Tahiri-Alaoui A, James W. Structural determinants of conformationally selective, prion-binding aptamers. J Biol Chem. 2004; 279: 13102-9
50. Green LS, Jellinek D, Jenison R, Östman A, Heldin C-H, Janjic N. Inhibitory DNA ligands to platelet-derived growth factor B-chain. Biochemistry. 1996; 35: 14413-24
51. Zuker M. Mfold web server for nucleic acid folding and hybridization prediction. Nucleic Acids Res. 2003; 31: 3406-15
52. Mei H, Bing T, Yang X, Qi C, Chang T, Liu X, et al. Functional-group specific aptamers indirectly recognizing compounds with alkyl amino group. Anal Chem. 2012; 84: 7323-9
53. Qi C, Bing T, Mei H, Yang X, Liu X, Shangguan D. G-quadruplex DNA aptamers for zeatin recognizing. Biosens Bioelectron. 2013; 41: 157-62
54. Yang X, Bing T, Mei H, Fang C, Cao Z, Shangguan D. Characterization and application of a DNA aptamer binding to L-tryptophan. Analyst. 2011; 136: 577-85
55. Bing T, Chang T, Yang X, Mei H, Liu X, Shangguan D. G-quadruplex DNA aptamers generated for systemin. Bioorg Med Chem. 2011; 19: 4211-9
56. Kimoto M, Yamashige R, Matsunaga K-i, Yokoyama S, Hirao I. Generation of high-affinity DNA aptamers using an expanded genetic alphabet. Nat Biotechnol. 2013; 31: 453-7
57. Xiao Z, Shangguan D, Cao Z, Fang X, Tan W. Cell-Specific Internalization Study of an Aptamer from Whole Cell Selection. Chem Eur J. 2008; 14: 1769-75
58. Chen Y, Munteanu AC, Huang YF, Phillips J, Zhu Z, Mavros M, et al. Mapping receptor density on live cells by using fluorescence correlation spectroscopy. Chem Eur J. 2009; 15: 5327-36
59. Nimjee SM, Rusconi CP, Sullenger BA. Aptamers: an emerging class of therapeutics. Annu Rev Med. 2005; 56: 555-83
60. Mallikaratchy P, Tang Z, Kwame S, Meng L, Shangguan D, Tan W. Aptamer directly evolved from live cells recognizes membrane bound immunoglobin heavy mu chain in Burkitt's lymphoma cells. Mol Cell Proteomics. 2007; 6: 2230-8
61. Yang Z, Chen F, Alvarado JB, Benner SA. Amplification, mutation, and sequencing of a six-letter synthetic genetic system. J Am Chem Soc. 2011; 133: 15105-12
62. O'Connor ML, Xiang D, Shigdar S, Macdonald J, Li Y, Wang T, et al. Cancer stem cells: a contentious hypothesis now moving forward. Cancer Lett. 2014; 344: 180-7
63. Sun H, Zu Y. Aptamers and their applications in nanomedicine. Small. 2015; 11: 2352-64
64. Xiang D, Shigdar S, Qiao G, Wang T, Kouzani AZ, Zhou S-F, et al. Nucleic acid aptamer-guided cancer therapeutics and diagnostics: the next generation of cancer medicine. Theranostics. 2015; 5: 23-42
65. Lv Y, Hu R, Zhu G, Zhang X, Mei L, Liu Q, et al. Preparation and biomedical applications of programmable and multifunctional DNA nanoflowers. Nat Protoc. 2015; 10: 1508-24
66. Fang X, Tan W. Aptamers generated from cell-SELEX for molecular medicine: a chemical biology approach. Acc Chem Res. 2009; 43: 48-57
67. Pu Y, Zhu Z, Liu H, Zhang J, Liu J, Tan W. Using aptamers to visualize and capture cancer cells. Anal Bioanal Chem. 2010; 397: 3225-33
68. Ye M, Hu J, Peng M, Liu J, Liu J, Liu H, et al. Generating aptamers by cell-SELEX for applications in molecular medicine. Int J Mol Sci. 2012; 13: 3341-53
69. Meyer C, Hahn U, Rentmeister A. Cell-Specific Aptamers as Emerging Therapeutics. J Nucleic Acids. 2011; 2011
70. Van Simaeys D, Turek D, Champanhac C, Vaizer J, Sefah K, Zhen J, et al. Identification of cell membrane protein stress-induced phosphoprotein 1 as a potential ovarian cancer biomarker using aptamers selected by cell systematic evolution of ligands by exponential enrichment. Anal Chem. 2014; 86: 4521-7
71. Yang M, Jiang G, Li W, Qiu K, Zhang M, Carter CM, et al. Developing aptamer probes for acute myelogenous leukemia detection and surface protein biomarker discovery. J Hematol Oncol. 2014; 7: 1-14
72. Raddatz MSL, Dolf A, Endl E, Knolle P, Famulok M, Mayer G. Enrichment of Cell-Targeting and Population-Specific Aptamers by Fluorescence-Activated Cell Sorting. Angew Chem Int Ed Engl. 2008; 47: 5190-3
73. Mayer G, Ahmed M-SL, Dolf A, Endl E, Knolle PA, Famulok M. Fluorescence-activated cell sorting for aptamer SELEX with cell mixtures. Nat Protoc. 2010; 5: 1993-2004
74. Hung L-Y, Wang C-H, Hsu K-F, Chou C-Y, Lee G-B. An on-chip Cell-SELEX process for automatic selection of high-affinity aptamers specific to different histologically classified ovarian cancer cells. Lab Chip. 2014; 14: 4017-28
75. Souza AG, Marangoni K, Fujimura PT, Alves PT, Silva MJ, Bastos VAF, et al. 3D Cell-SELEX: Development of RNA aptamers as molecular probes for PC-3 tumor cell line. Exp Cell Res. 2016; 341: 147-56